Cargando…
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges
Cardiovascular diseases (CVD) are the leading cause of mortality in Western countries. CVD include several pathologies, such as coronary artery disease, stroke, peripheral artery disease, and aortic aneurysm, among others. All of them are characterized by a pathological vascular remodeling in which...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072601/ https://www.ncbi.nlm.nih.gov/pubmed/32053869 http://dx.doi.org/10.3390/cells9020405 |
_version_ | 1783506444513968128 |
---|---|
author | Méndez-Barbero, Nerea Gutiérrez-Muñoz, Carmen Blázquez-Serra, Rafael Martín-Ventura, Jose L. Blanco-Colio, Luis M. |
author_facet | Méndez-Barbero, Nerea Gutiérrez-Muñoz, Carmen Blázquez-Serra, Rafael Martín-Ventura, Jose L. Blanco-Colio, Luis M. |
author_sort | Méndez-Barbero, Nerea |
collection | PubMed |
description | Cardiovascular diseases (CVD) are the leading cause of mortality in Western countries. CVD include several pathologies, such as coronary artery disease, stroke, peripheral artery disease, and aortic aneurysm, among others. All of them are characterized by a pathological vascular remodeling in which inflammation plays a key role. Interaction between different members of the tumor necrosis factor superfamily and their cognate receptors induce several biological actions that may participate in CVD. The cytokine tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its functional receptor, fibroblast growth factor-inducible 14 (Fn14), are abundantly expressed during pathological cardiovascular remodeling. The TWEAK/Fn14 axis controls a variety of cellular functions, such as proliferation, differentiation, and apoptosis, and has several biological functions, such as inflammation and fibrosis that are linked to CVD. It has been demonstrated that persistent TWEAK/Fn14 activation is involved in both vessel and heart remodeling associated with acute and chronic CVD. In this review, we summarized the role of the TWEAK/Fn14 axis during pathological cardiovascular remodeling, highlighting the cellular components and the signaling pathways that are involved in these processes. |
format | Online Article Text |
id | pubmed-7072601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70726012020-03-19 Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges Méndez-Barbero, Nerea Gutiérrez-Muñoz, Carmen Blázquez-Serra, Rafael Martín-Ventura, Jose L. Blanco-Colio, Luis M. Cells Review Cardiovascular diseases (CVD) are the leading cause of mortality in Western countries. CVD include several pathologies, such as coronary artery disease, stroke, peripheral artery disease, and aortic aneurysm, among others. All of them are characterized by a pathological vascular remodeling in which inflammation plays a key role. Interaction between different members of the tumor necrosis factor superfamily and their cognate receptors induce several biological actions that may participate in CVD. The cytokine tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its functional receptor, fibroblast growth factor-inducible 14 (Fn14), are abundantly expressed during pathological cardiovascular remodeling. The TWEAK/Fn14 axis controls a variety of cellular functions, such as proliferation, differentiation, and apoptosis, and has several biological functions, such as inflammation and fibrosis that are linked to CVD. It has been demonstrated that persistent TWEAK/Fn14 activation is involved in both vessel and heart remodeling associated with acute and chronic CVD. In this review, we summarized the role of the TWEAK/Fn14 axis during pathological cardiovascular remodeling, highlighting the cellular components and the signaling pathways that are involved in these processes. MDPI 2020-02-11 /pmc/articles/PMC7072601/ /pubmed/32053869 http://dx.doi.org/10.3390/cells9020405 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Méndez-Barbero, Nerea Gutiérrez-Muñoz, Carmen Blázquez-Serra, Rafael Martín-Ventura, Jose L. Blanco-Colio, Luis M. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges |
title | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges |
title_full | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges |
title_fullStr | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges |
title_full_unstemmed | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges |
title_short | Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges |
title_sort | tumor necrosis factor-like weak inducer of apoptosis (tweak)/fibroblast growth factor-inducible 14 (fn14) axis in cardiovascular diseases: progress and challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072601/ https://www.ncbi.nlm.nih.gov/pubmed/32053869 http://dx.doi.org/10.3390/cells9020405 |
work_keys_str_mv | AT mendezbarberonerea tumornecrosisfactorlikeweakinducerofapoptosistweakfibroblastgrowthfactorinducible14fn14axisincardiovasculardiseasesprogressandchallenges AT gutierrezmunozcarmen tumornecrosisfactorlikeweakinducerofapoptosistweakfibroblastgrowthfactorinducible14fn14axisincardiovasculardiseasesprogressandchallenges AT blazquezserrarafael tumornecrosisfactorlikeweakinducerofapoptosistweakfibroblastgrowthfactorinducible14fn14axisincardiovasculardiseasesprogressandchallenges AT martinventurajosel tumornecrosisfactorlikeweakinducerofapoptosistweakfibroblastgrowthfactorinducible14fn14axisincardiovasculardiseasesprogressandchallenges AT blancocolioluism tumornecrosisfactorlikeweakinducerofapoptosistweakfibroblastgrowthfactorinducible14fn14axisincardiovasculardiseasesprogressandchallenges |